Anal Cancer News
Anal Cancer News
Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)
People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying... Continue Reading
The number of people in the United States with anal cancer has tripled since the 1970s, according to the results of a study published in the Journal of Clinical Oncology. Anal cancer is an uncommon type... Continue Reading
Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National... Continue Reading
Nearly one-third of men with anal cancer have the human immunodeficiency virus (HIV), according to the results of a study published in the Journal of the National Cancer Institute. Anal cancer is an uncommon... Continue Reading
Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according... Continue Reading
A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing... Continue Reading
Live Web Chat with Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service; Laurance S. Rockefeller Chair Integrative Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), click here for Dr.... Continue Reading
The Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention (CDC) has recommended that boys be vaccinated against human papillomavirus (HPV). Human papillomaviruses... Continue Reading
According to a study presented at the 2011 European Multidisciplinary Cancer Congress, children born to women who received chemotherapy during pregnancy do not appear to have an increased risk of heart... Continue Reading
Cervarix® (human papillomavirus bivalent [types 16 and 18] recombinant vaccine), an FDA-approved vaccine for the prevention of cervical cancer, may also help prevent anal cancer. These findings were recently... Continue Reading
Latest Anal Cancer News By Stage
Screening/Prevention
Anal Cancer Rates Appear to Be On the Rise in the U.S. (May 6, 2013)
The number of people in the United States with anal cancer has tripled since the 1970s, according to the results of a study published in the Journal of Clinical Oncology. Anal cancer is an uncommon type of cancer that occurs in the anal canal, the opening... Continue Reading
Anal Cancer on the Rise in Men with HIV (October 15, 2012)Nearly one-third of men with anal cancer have the human immunodeficiency virus (HIV), according to the results of a study published in the Journal of the National Cancer Institute. Anal cancer is an uncommon type of cancer that occurs in the anal canal,... Continue Reading
HPV Vaccine Reducing Infection among Vaccinated and Unvaccinated (July 16, 2012)The human papillomavirus (HPV) vaccine is reducing infections of virus strains associated with genital warts and cancer, even among those who remain unvaccinated, according to the results of a study published in Pediatrics. HPV is the most common sexually... Continue Reading
Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading
HPV Vaccine May Prevent Anal Cancer (September 14, 2011)Cervarix® (human papillomavirus bivalent [types 16 and 18] recombinant vaccine), an FDA-approved vaccine for the prevention of cervical cancer, may also help prevent anal cancer. These findings were recently reported in Lancet Oncology. Human papillomaviruses... Continue Reading
More Screening and PreventionStages I-II
Intensity-Modulated Radiation Therapy Reduces Side Effects for Patients with Anal Cancer (January 31, 2011)
Treatment of anal cancer with chemotherapy and intensity-modulated radiation therapy (IMRT) may be as effective as treatment with conventional radiation and chemotherapy but with fewer side effects. These findings were presented at the eighth annual Gastrointestinal... Continue Reading
Sandostatin Ineffective in Preventing Diarrhea in Anal and Rectal Cancer Patients Treated with Chemoradiotherapy (March 30, 2010)Sandostatin® (ocreotide acetate) does not prevent diarrhea in patients with anal or rectal cancer treated with chemotherapy and radiation therapy. The results of this randomized, double-blind, placebo controlled trial were recently reported in the Journal... Continue Reading
No Benefit with Addition of Platinol® to Treatment for Anal Cancer (May 1, 2008)No Benefit with Addition of Platinol® to Treatment for Anal Cancer Addition of the drug Platinol® (cisplatin) to 5-FU (5-flourouracil), mitomycin, and radiation may not improve outcomes for patients with anal cancer. These findings were recently published... Continue Reading
5-FU/Mitomycin Remains Standard of Care for Anal Cancer (July 26, 2006)5-FU/Mitomycin Remains Standard of Care for Anal Cancer According to results recently reported at the 2006 semi-annual meeting of the Radiation Therapy Oncology Group (RTOG), treatment including the chemotherapy agents 5-fluorouracil?and?mitomycin-C (Mutomycin?)... Continue Reading
Radiation to the Pelvis Increases Risk of Pelvic Fractures (November 28, 2005)Radiation to the Pelvis Increases Risk of Pelvic Fractures According to a recent article published in the Journal of the American Medical Association (JAMA), women who undergo radiation to the pelvis for cancers of the cervix, rectum, or anus are at an... Continue Reading
More Stages I-IIStages IV
Factors Affecting Quality of Life at the End of Life (July 20, 2012)
For people with advanced cancer, quality of life at the end of life—sometimes referred to as “a good death”—may have less to do with medical treatment and more to do with a therapeutic alliance with their physicians, according to the results of... Continue Reading
Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival or duration of functional independence but does... Continue Reading
Sandostatin Ineffective in Preventing Diarrhea in Anal and Rectal Cancer Patients Treated with Chemoradiotherapy (March 30, 2010)Sandostatin® (ocreotide acetate) does not prevent diarrhea in patients with anal or rectal cancer treated with chemotherapy and radiation therapy. The results of this randomized, double-blind, placebo controlled trial were recently reported in the Journal... Continue Reading
No Benefit with Addition of Platinol® to Treatment for Anal Cancer (May 1, 2008)No Benefit with Addition of Platinol® to Treatment for Anal Cancer Addition of the drug Platinol® (cisplatin) to 5-FU (5-flourouracil), mitomycin, and radiation may not improve outcomes for patients with anal cancer. These findings were recently published... Continue Reading
5-FU/Mitomycin Remains Standard of Care for Anal Cancer (July 26, 2006)5-FU/Mitomycin Remains Standard of Care for Anal Cancer According to results recently reported at the 2006 semi-annual meeting of the Radiation Therapy Oncology Group (RTOG), treatment including the chemotherapy agents 5-fluorouracil?and?mitomycin-C (Mutomycin?)... Continue Reading
More Stage IVRecurrent
Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)
Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival or duration of functional independence but does... Continue Reading
Sandostatin Ineffective in Preventing Diarrhea in Anal and Rectal Cancer Patients Treated with Chemoradiotherapy (March 30, 2010)Sandostatin® (ocreotide acetate) does not prevent diarrhea in patients with anal or rectal cancer treated with chemotherapy and radiation therapy. The results of this randomized, double-blind, placebo controlled trial were recently reported in the Journal... Continue Reading
Surgical Salvage Therapy is Effective Treatment for Patients with Rectal Cancer that Relapse Locally after Initial Sphincter-Conserving Treatment (February 4, 2002)Surgical Salvage Therapy is Effective Treatment for Patients with Rectal Cancer that Relapse Locally after Initial Sphincter-Conserving Treatment The standard of care for most patients with anal cancer is now initial treatment with radiation or chemoradiotherapy,... Continue Reading
More Recurrent
